The diagnosis and medical management of advanced neuroendocrine tumors.
The DOI matches its Crossref record; 657 of the 670 references it cites were found in a registry or an index.
Abstract
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that originate from endocrine glands such as the pituitary, the parathyroids, and the (neuroendocrine) adrenal, as well as endocrine islets within glandular tissue (thyroid or pancreatic) and cells dispersed between exocrine cells, such as endocrine cells of the digestive (gastroenteropancreatic) and respiratory tracts. Conventionally, NETs may present with a wide variety of functional or nonfunctional endocrine syndromes and may be familial and have other associated tumors. Assessment of specific or general tumor markers offers high sensitivity in establishing the diagnosis and can also have prognostic significance. Imaging modalities include endoscopic ultrasonography, computed tomography and magnetic resonance imaging, and particularly, scintigraphy with somatostatin analogs and metaiodobenzylguanidine. Successful treatment of disseminated NETs requires a multimodal approach; radical tumor surgery may be curative but is rarely possible. Well-differentiated and slow-growing gastroenteropancreatic tumors should be treated with somatostatin analogs or alpha-interferon, with chemotherapy being reserved for poorly differentiated and progressive tumors. Therapy with radionuclides may be used for tumors exhibiting uptake to a diagnostic scan, either after surgery to eradicate microscopic residual disease or later if conventional treatment or biotherapy fails. Maintenance of the quality of life should be a priority, particularly because patients with disseminated disease may experience prolonged survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the combination of noninvasive and selected invasive modalities (particularly endoscopic ultrasound), most insulinomas are localized preoperatively (72, 78).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [72]
In the citing paper
“Although the results with a given method reflect the experience and expertise with that method at a given center, computed tomography, MRI, and transabdominal ultrasonography detect most insulinomas (71-73).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [72]
Citations
Cites
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
Gutmann, D. H. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550010065042 · Cited by 1,359
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
The Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity
CARNEY, J. A., GORDON, H., CARPENTER, P. C., SHENOY, B. V., & W. GO, V. L. (1985) · Medicine · doi:10.1097/00005792-198507000-00007 · Cited by 1,114
Research works printed but not linked: 3
- Krenning, 1994, Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide., Semin Oncol, 21, 6
- Janson, 2000, Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors., J Nucl Med, 41, 1514
- Bartsch, 1990, Treatment of metastatic carcinoid tumors by recombinant human interferon-α. Results from a phase II study., J Cancer Res Clin Oncol, 116, 305
Cited by
Items 601–679 of 679
An incredibly dilated Wirsung mimicking a sero-cystic neoplasm of the pancreatic head
Vergani, C., Messina, M., Giusti, I., & Venturi, M. (2018) · Journal of Surgical Case Reports · doi:10.1093/jscr/rjy122
“Preoperative work-up was consistent with a neuroendocrine pancreatic tumor, probably a somatostatinoma [1, 2].”
BackgroundThe Role of Platelet Derived Growth Factor Receptor in Neuroendocrine Tumours
Ko, Y. M. (2014) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3pk0792t
Amalraj, S., & Naeim, A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1398-5.10003-7
Malignant retroperitoneal paraganglioma treated with radiotherapy: A case report
Ghammad, S., Hassani, G. C., Allouche, F., Alami, Z., Bouhafa, T., & Hassouni, K. (2018) · Journal of Surgery and Medicine · doi:10.28982/josam.456705
Metastatic malignant liver tumors
Khan, S., Nagorney, D. M., & Que, F. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1454-8.00127-2
Sayán, O. C., Sánchez, C. M., Rubio, R. V., Zuñiga, E. M., Pérez, G. M., & Cebreros, L. T. (2018) · Anales de la Facultad de Medicina · doi:10.15381/anales.v79i4.15637
Sandblom, V., Ståhl, I., Hansson, C., Bagge, R. O., & Forssell-Aronsson, E. B. (2019) · Surgical Oncology · doi:10.1016/j.suronc.2019.05.002
Subtotal Gastrectomy for Atypical Carcinoid of Stomach– A Rare Tumour
Hossain, S. S., Rahman, M. M., Mahmud, M. R., & Jahan, F. I. (2016) · Journal of Armed Forces Medical College Bangladesh · doi:10.3329/jafmc.v12i2.41112
Radioembolization in the Treatment of Neuroendocrine Tumors
Özkan, Z. G. (2019) · Nuclear Medicine Seminars · doi:10.4274/nts.galenos.2019.0020
“NET’lerin, nöroamin ve peptidleri sentezleme, depolama ve sekrete edebilme özellikleri bulunur (3).”
BackgroundCromogranina A en el diagnóstico y seguimiento de los tumores endocrinos gastroenteropancreáticos
Aller, J., Domínguez, R., Estrella, A., & Estrada, J. S. (2008) · Endocrinología y Nutrición · Cited by 1
Nño, F. (2008) · Revista Repertorio de Medicina y Cirugía · doi:10.31260/repertmedcir.v17.n4.2008.518
Hepatic metastasis from neuroendocrine cancers
Smoot, R. L., Khan, S., & Nagorney, D. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-34062-5.00093-5
Hypercalcitoninemia and Insulinoma – a rare association
Dias, D., Luíz, H. V., OLIVEIRA, J. D. C., Sequeira, P., & Portugal, J. (2020) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/cc190049
Pérez, D. J., & Avila-Rodriguez, M. A. (2020) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-020-07437-6
Gastric Tumors (Other than Adenocarcinoma)
Pitchumoni, C. S., Chaubal, A., & Desai, G. (2021) · Springer eBooks · doi:10.1007/978-3-319-90761-1_117-1
Manivannan, S., Sharouf, F., Lammie, G. A., & Leach, P. A. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-236856
Neumann, T. (2021) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-29555
Ravizza, D., & Fiori, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-72830-4_13
Non-functional neuroendocrine tumor with multisystemic metastasis in a cat
Baêta, S. D. A. F., Abreu, D. M., Sousa, J. A. C., Farias, I. S., Sá, I. D. S., Silva, S. M. M. D. S., Serákides, R., & Ocarino, N. M. (2021) · Brazilian Journal of Veterinary Pathology · doi:10.24070/bjvp.1983-0246.v14i2p117-122
Dinter, H. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8561
Khanna, A., Cianci, N., Shah, H. A., Goel, A., Jebril, A., Chauhan, J., Pipe, M., Shetty, S., Weston, C. J., Venkataraman, H., et al. (2021) · GastroHep · doi:10.1002/ygh2.491
Clement, D., Srirajaskanthan, R., & Caplin, M. E. (2022) · doi:10.1093/med/9780198870197.003.0108
Pancreatic Neuroendocrine Tumors
Tsolakis, A. V., & Kanakis, G. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_50
Huppert, P. E., Kortes, N., Kratochwil, C., Radeleff, B. A., Schmitz, Ä., & Stampfl, U. (2020) · Springer eBooks · doi:10.1007/978-3-662-56243-7_14
Gianotti, L., Picu, A., Lanfranco, F., Tassone, F., Baldi, M., Giordano, R., Ghigo, E., & Maccario, M. (2007) · Springer eBooks · doi:10.1007/978-88-470-0552-5_29
Manfredi, R. M., Castelli, F., Foti, G., Zantedeschi, L., Ventriglia, A., & Mucelli, R. P. (2013) · Springer eBooks · doi:10.1007/978-88-470-2844-9_8
Salazar, R. (2007) · Medicina Clínica · doi:10.1016/s0025-7753(07)72588-5
Igaz, P., Rácz, K., & Tulassay, Z. (2007) · Hungarian Medical Journal · doi:10.1556/hmj.1.2007.28231
Gastroenteropancreatic Neuroendocrine Neoplasms
Gotfrit, J., & Asmis, T. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65749-5
Mucelli, R. P., Foti, G., & Romano, L. (2012) · Updates in surgery/Updates in surgery series · doi:10.1007/978-88-470-2673-5_9
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000235329.84906.3b
(2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3256-4.50086-7
Mass, F. J. T., & Gonzlez, J. M. R. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73192-8 · Cited by 2
Smit, J. W. A., Lips, C. J. M., Links, T. P., Pereira, A. M., Corssmit, E. P. M., Dekkers, O. M., Kievit, J., Haak, H. R., Romijn, J. A., Lips, P. T. A. M., et al. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8476-1_29 · Cited by 1
Rare Orbitocranial Tumour in an Adult
Mehta, A., & Chandra, M. (2009) · Orbit · doi:10.1080/01676830902932418
“…mass may possibly have been the primary lesion, although an occult gastrointestinal or pulmonary primary tumour can occasionally be detected by specialized techniques (Kaltsas et al., 2004; Boubaker et al., 2003; Srivastava et al., 2004; Brambilla et al., 2001; D’Herbomez et al., 2001).”
InfluentialClinical Approaches to the Management of Neuroendocrine Tumours
Yim, K.-L., Thomas, B. M., & Christian, A. D. (2019) · Springer eBooks · doi:10.1007/978-3-030-16245-0_38
Oncological Pathology of The Endocrine System
Huñis, A. P. (2022) · Journal of Endocrinology and Metabolism Research · doi:10.37191/mapsci-2582-7960-3(2)-027
Pérez, D. J., Razo‐Hernández, R. S., & Avila-Rodriguez, M. A. (2023) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520623666230104160635
Mujer con diarrea crónica, flushing y disnea de esfuerzo: síndrome de Hedinger
García-Ramos, H. M., Begazo-Bellido, J. M., & Liendo-Caro, G. R. (2023) · Boletín de la Sociedad Peruana de Medicina Interna/Revista de la Sociedad Peruana de Medicina Interna · doi:10.36393/spmi.v36i1.723
Role of high dose octreotide LAR for the treatment of GEP-NETs
Franchi, G. M., Cappelletti, C., Villa, V. V., Bosi, E., & Manzoni, M. F. (2009) · Clinical Management Issues · doi:10.7175/cmi.v3i1.555
Estudo de fase II piloto de metformina em pacientes com tumores neuroendócrinos bem diferenciados
Glasberg, J. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-12042023-160353
Fotiadis, D. I., Sakellarios, A. I., & Potsika, V. T. (2023) · Wiley eBooks · doi:10.1002/9781119819028.ch2
Neuroendocrine Tumor of the Appendix: A Case Report and Review of Literature
Chettahi, N., Mahmoudi, A., Alaoui, O., Khattala, K., & Bouabdallah, Y. (2023) · SAR Journal of Medical Case Reports · doi:10.36346/sarjmcr.2023.v04i02.002
Epidemiology and Classification of Neuroendocrine Tumors of the Pancreas
Mukherjee, J. J., Lee, K., & Kaltsas, G. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch98
Self-citationEffects of COVID-19 on Serotonin and Dopamine Levels: A Review Study
Hashemzadeh, M., & Jamali, N. (2022) · مجله علمی پزشکی جندی شاپور · doi:10.32598/jsmj.21.5.2834
Emelianov, G. S., Горбунова, В. А., Федоровна, О. Н., Маркович, А. А., Kuzmiovn, A. E., & Selchuk, V. Y. (2014) · Russian Journal of Oncology · doi:10.17816/onco40104
Mixed Adenoneuroendocrine Carcinoma in the Colon: A Case Report
Mollaoğlu, M. C. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005028
Alekseenko, I. D. (2024) · Vestnik of M Kozybayev North Kazakhstan University · doi:10.54596/2958-0048-2024-2-15-21
VIPoma, glucagonoma, and somatostatinoma
Hofland, J., & de Herder, W. W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00060-1
Advances in Radionuclide Therapies for Neuroendocrine Tumor Liver Metastases
Ebbers, S. C. (2024) · Utrecht University Repository (Utrecht University) · doi:10.33540/2348
Advances in Non-Surgical Management of Neuroendocrine Neoplasms
倪, 寇. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541263
Tsoli, M., & Kaltsas, G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00189-8
Self-citationKim, S. J., Cha, J., Lee, H. S., Chung, M. J., Park, J. Y., Bang, S., Park, S. W., Song, S. Y., Cho, A. E.-H., & Jo, J. H. (2025) · Cancers · doi:10.3390/cancers17091487
“Pancreatic NET (pNET) has an exceptionally high risk of metastasis, with small lesions exhibiting a metastasis rate of approximately 15% [20–22].”
Debulking surgery for small intestine neuroendocrine tumors
Диникин, М. С., Иванова, А. К., Орлова, Р. В., & Пелипась, Ю. В. (2025) · Clinical Case in Oncology · doi:10.62546/3034-1477-2024-2-4-52-66
Tumoración neuroendocrina de íleon, el desenlace de un diagnóstico inoportuno
Cruz-Contreras, S., Becerril-Mireles, D., Becerril-Gómez, I., Sánchez-García, M., & Fuentes-Rivas, A. (2025) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2025.04.001
Neuroendocrine Tumors: Radiopharmaceuticals for Imaging and Therapy
Sharma, P., & Singh, S. S. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837677139-00309
Unmasking an insulinoma: From biochemical to pathological diagnosis
Mach, T., Walfish, L., & Pancer, J. (2025) · Canadian Journal of General Internal Medicine · doi:10.3138/cjgim.2024.0015
Hyperferritinemia as a Clue to Neuroendocrine Carcinoma
Chao, E. S., Yoshikawa, G. T., Qing, X., & Huang, C. A. (2025) · Cureus · doi:10.7759/cureus.90020
Neuroendocrine tumor of the ileum: The outcome of an untimely diagnosis
Cruz-Contreras, S., Becerril-Mireles, D., Becerril-Gómez, I., Sánchez-García, M., & Fuentes-Rivas, A. (2025) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2025.09.018
Pulmonary Lymphangitic Carcinomatosis of Small Cell Lung Carcinoma: An Autopsy Case Report
Albuquerque, R. M., de Mello, G. N., Lopes, M. C. N., Gomes, M. L., & Neto, A. N. D. (2025) · Brazilian Journal of Case Reports · doi:10.52600/2763-583x.bjcr.2026.6.1.bjcr119
“Some are well differentiated, with slow growth and hormonal secretion, often allowing recognition of the primary site based on morphology and immunohistochemistry [6].”
Metastatic Nonfunctional Pancreatic Neuroendocrine Tumor – Case Report and Review of the Literature
Tankova, L., Gerova, В., Getsov, P. G., Nakov, R., Churchev, S., Terziev, I., Kostadinova, I., Vitkova, М., Nakov, V., Damyanov, D., et al. (2015) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-3-7-6
“There is an increase by 5 times in the detection rate of NET′s in the last two decades, partly due to improved radiological diagnostic techniques [5,6].”
BackgroundShi, H., Jiang, C., Zhang, Q., Qi, C., Yao, H., & Lin, R. (2020) · Figshare · doi:10.6084/m9.figshare.12948086
Ανοσοϊστοχημική μελέτη του μεταγραφικού παράγοντα INSM1 στον μικροκυτταρικό καρκίνο του πνεύμονα
Λιάκου, Ζ. (2020) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.9408
Familiäre Ursachen bei endokrinen Tumorsyndromen: Ergebnisse aus Segregationsanalysen
Ghiasi, M. (2021) · Gutenberg Open Science · doi:10.25358/openscience-6161
Uribe Muñoz, C. F. (2016) · cIRcle (University of British Columbia) · Cited by 1
Gupta, A., Hari, V., Shenoy, D., & Mahabala, C. (2025) · F1000Research · doi:10.12688/f1000research.163913.2
Armstrong, V. L., & Vaghaiwalla, T. M. (2025) · Difficult decisions in surgery: an evidence-based approach · doi:10.1007/978-3-032-05288-9_35
Pérez, J. P. (2024) · e_Buah
Talib, A. I., Marks, C., & Saleem, S. (2026) · Clinical Case Reports · doi:10.1002/ccr3.71719
Caractérisation multiparamétrique des cancers de l’oesophage et de l’estomac
Quéré, G. (2018) · theses.fr (ABES) · doi:10.70675/115724f8z1764z444bz9785z1815bdcd3dc0
Streit, L. (2021) · theses.fr (ABES) · doi:10.70675/3269cd86zf5cez4e27z8df0zbfdff2079072
Schoorens, K., Santa, L., & Mattina, A. J. D. (2025) · Clinical Insights in Eyecare · doi:10.66574/001c.140872
Molecular Testing in Neuroendocrine Tumours
Evan, T., Srirajaskanthan, R., & Sarker, D. (2026) · Current clinical pathology · doi:10.1007/978-3-032-18790-1_17
Li, L., Yin, H., He, A., Ye, Y., & Zhang, Y. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1816591
“Neuroendocrine cells can produce, store and secrete various bioactive substances, thereby causing dierent clinical syndromes (7).”
Asmundo, L., Blandino, A. A., Quiros, E., Zhang, M. L., Cañamaque, L. G., Field, C. A., Kako, B., Leithner, D., Vanzulli, A., & Catalano, O. A. (2026) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2026.500361
Carcinoid heart disease : diagnosis, investigation, progression and management
Bhattacharyya, S. (2011) · UCL Discovery (University College London)
Metadata
- Authors
- Kaltsas, G. A., Besser, G. M., & Grossman, A. B.
- Affiliations
- St Bartholomew's Hospital (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-06-01
- Volume
- 25
- Issue
- 3
- Pages
- 458-511
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2031301095
- Semantic Scholar
- b09a37699a89446c4662f1bc87eb975bf31118b7
- Cited by
- 674
- References
- 670
- Citations by year
- 2026: 4 · 2025: 19 · 2024: 17 · 2023: 26 · 2022: 17 · 2021: 23 · 2020: 23 · 2019: 24 · 2018: 31 · 2017: 27 · 2016: 34 · 2015: 46 · 2014: 30 · 2013: 37 · 2012: 49
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- neuroendocrine tumors, diagnosis, tumor markers, endocrine syndromes, somatostatin analogues, MIBG scintigraphy, endoscopic ultrasound, interferon-alpha, chemotherapy, radionuclide therapy, multimodal therapy, quality of life
- MeSH terms
- Adrenal Gland Neoplasms, Animals, Antineoplastic Combined Chemotherapy Protocols, Gastrointestinal Neoplasms, Humans, Pancreatic Neoplasms, Parathyroid Neoplasms, Pituitary Neoplasms, Prognosis, Quality of Life, Sensitivity and Specificity, Somatostatin, Thyroid Neoplasms, Tomography, X-Ray Computed, Biomarkers, Tumor, Interferon-alpha, Carcinoma, Neuroendocrine, Neuroendocrine Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.